Meinian Onehealth Healthcare Holdings Co., Ltd. (SHE:002044)
China · Delayed Price · Currency is CNY 4.350
+0.010 (0.23%)
Sep 16, 2026, 3:04 PM CST
SHE:002044 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 10,027 | 10,296 | 10,657 | 10,870 | 8,602 | 9,200 |
Other Revenue | 67.79 | 63.28 | 45.22 | 23.21 | 14.18 | 15.96 |
| 10,095 | 10,360 | 10,702 | 10,894 | 8,616 | 9,216 | |
Revenue Growth | -4.82% | -3.20% | -1.76% | 26.44% | -6.51% | 17.43% |
Cost of Revenue | 5,864 | 6,075 | 6,123 | 6,232 | 5,649 | 5,580 |
Gross Profit | 4,230 | 4,285 | 4,579 | 4,661 | 2,967 | 3,636 |
Selling, General & Admin | 3,115 | 3,201 | 3,430 | 3,395 | 2,863 | 2,819 |
Research & Development | 55.68 | 52.69 | 54.96 | 62.65 | 56.35 | 60.22 |
Other Operating Expenses | 11.22 | 3.59 | 4.96 | 3.73 | 2.6 | 1.76 |
Operating Expenses | 3,311 | 3,387 | 3,626 | 3,446 | 3,074 | 2,962 |
Operating Income | 919 | 897.13 | 952.39 | 1,216 | -106.83 | 674.33 |
Interest Expense | -285.99 | -304.38 | -319.37 | -303.68 | -291.43 | -353.66 |
Interest & Investment Income | 43.78 | 45.99 | 25.11 | 21.63 | 14.06 | 88.04 |
Currency Exchange Gain (Loss) | 0.05 | 0.01 | 0.03 | -0.02 | -0.33 | 2.17 |
Other Non Operating Income (Expenses) | -12.89 | -17.76 | -20.21 | -33.94 | -24.98 | -32.81 |
EBT Excluding Unusual Items | 663.95 | 620.99 | 637.95 | 899.55 | -409.52 | 378.07 |
Impairment of Goodwill | -40.11 | -40.11 | -6.71 | -41.86 | - | - |
Gain (Loss) on Sale of Investments | 5.64 | 17.63 | -29.37 | 1.78 | 5.84 | -0.57 |
Gain (Loss) on Sale of Assets | -7.63 | -10.2 | -8.49 | -6.89 | -8.16 | -6.17 |
Asset Writedown | -34.66 | -34.58 | -18.24 | -26.96 | -66.84 | -28.27 |
Legal Settlements | - | - | - | - | - | -7.92 |
Other Unusual Items | 28.79 | 3.73 | 17.37 | 22.43 | 27.96 | 29.61 |
Pretax Income | 615.98 | 557.45 | 592.52 | 848.06 | -450.72 | 364.75 |
Income Tax Expense | 214.47 | 186.87 | 183.53 | 179.23 | 50.86 | 205.57 |
Earnings From Continuing Operations | 401.51 | 370.58 | 408.99 | 668.82 | -501.58 | 159.19 |
Minority Interest in Earnings | -77.21 | -85.26 | -126.75 | -163.2 | -57.44 | -97.61 |
Net Income | 324.3 | 285.33 | 282.24 | 505.62 | -559.02 | 61.58 |
Net Income to Common | 324.3 | 285.33 | 282.24 | 505.62 | -559.02 | 61.58 |
Net Income Growth | 17.22% | 1.09% | -44.18% | - | - | -88.83% |
Shares Outstanding (Basic) | 4,055 | 4,076 | 4,032 | 3,889 | 3,993 | 3,079 |
Shares Outstanding (Diluted) | 4,055 | 4,076 | 4,032 | 3,889 | 3,993 | 3,079 |
Shares Change | -0.57% | 1.09% | 3.67% | -2.60% | 29.69% | -21.77% |
EPS (Basic) | 0.08 | 0.07 | 0.07 | 0.13 | -0.14 | 0.02 |
EPS (Diluted) | 0.08 | 0.07 | 0.07 | 0.13 | -0.14 | 0.02 |
EPS Growth | 17.89% | 0% | -46.15% | - | - | -85.71% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 1,383 | 1,381 | 1,216 | 1,616 | 1,128 | 1,624 |
Free Cash Flow Per Share | 0.34 | 0.34 | 0.30 | 0.41 | 0.28 | 0.53 |
Dividend Per Share | 0.009 | 0.009 | 0.013 | 0.019 | - | - |
Dividend Growth | -33.33% | -33.33% | -28.95% | - | - | - |
Gross Margin | 41.91% | 41.36% | 42.78% | 42.79% | 34.44% | 39.46% |
Operating Margin | 9.10% | 8.66% | 8.90% | 11.16% | -1.24% | 7.32% |
Profit Margin | 3.21% | 2.75% | 2.64% | 4.64% | -6.49% | 0.67% |
Free Cash Flow Margin | 13.70% | 13.33% | 11.36% | 14.83% | 13.09% | 17.62% |
EBITDA | 1,319 | 1,338 | 1,430 | 1,672 | 337.89 | 1,094 |
EBITDA Margin | 13.07% | 12.91% | 13.37% | 15.35% | 3.92% | 11.87% |
D&A For EBITDA | 400.43 | 440.41 | 478 | 456.19 | 444.73 | 419.94 |
EBIT | 919 | 897.13 | 952.39 | 1,216 | -106.83 | 674.33 |
EBIT Margin | 9.10% | 8.66% | 8.90% | 11.16% | -1.24% | 7.32% |
Effective Tax Rate | 34.82% | 33.52% | 30.97% | 21.13% | - | 56.36% |
Revenue as Reported | 10,095 | 10,360 | 10,702 | 10,894 | 8,616 | 9,216 |
Advertising Expenses | - | 79.41 | 100.49 | 72.53 | 67.81 | 94.96 |